Friday, November 22, 2013
Print Current Day:
|
|
SESSION 65 SCHEDULE | |
Friday
SESSION 65:
NEW DEVELOPMENTS IN TREATMENT OF AAAs
Moderators:Michael L. Marin, MD / Kenneth Ouriel, MD, MBA, FACS, FACC
|
|
x | |
6:55 AM - 7:00 AM | A Way To Simplify FEVAR With Difficult Anatomy: Sequential Catheterizations And Progressive Endograft Deployment: The SCAPED Technique |
Presenter(s):Carlos H. Timaran, MD | |
7:01 AM - 7:06 AM | Can We Reduce Follow-up Protocols After EVAR For Some Patients: How Can It Be Done And In Which Patients |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
7:07 AM - 7:12 AM | PET CT Can Predict Rupture Risk In Small AAAs And Safety In Following Large AAAs |
Presenter(s):Natzi Sakalihasan, MD, PhD | |
7:13 AM - 7:18 AM | What Is The Role For Open AAA Repair In The Endovascular Era: Who Should Be Doing It |
Presenter(s):Karl H. Orend, MD | |
7:19 AM - 7:24 AM | Are All Inflammatory AAAs Best Treated By EVAR |
Presenter(s):Manju Kalra, MBBS | |
View Abstract | |
7:25 AM - 7:30 AM | Operative Management Of AAAs In Infants And Early Childhood: What Are They Due To And What Are The Long-Term Results |
Presenter(s):James C. Stanley, MD | |
View Abstract | |
7:31 AM - 7:36 AM | How To Do EVAR As An Outpatient Procedure: Experience In >100 Patients Show There Is No Downside And Many Advantages |
Presenter(s):Mario Lachat, MD / Jacques Bleyn, MD | |
7:37 AM - 7:42 AM | Changes In EVAR Outcomes Over The Last 10 Years: Comparison Of EUROSTAR And ENGAGE Registry Results: Why Is There A Difference |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
7:43 AM - 7:48 AM | Towards The Prevention Of Secondary Sac Rupture After EVAR |
Presenter(s):Roger M. Greenhalgh, MD | |
7:49 AM - 7:54 AM | DEBATE: Late Results Of The OVER And EVAR Trials Show That EVAR Is No Better Than Open Repair |
Presenter(s):Frank A. Lederle, MD | |
7:55 AM - 8:00 AM | DEBATE: Nonsense: The Late Results Of OVER And EVAR Prove EVAR Is Better |
Presenter(s):Juan C. Parodi, MD / Benjamin W. Starnes, MD / Christopher J. Kwolek, MD / Frank J. Veith, MD | |
8:01 AM - 8:06 AM | EVAR Does Make A Difference And Improves Overall Outcomes Of Elective And Ruptured AAAs Despite The Trials: Based On Information From The US Medicare Database |
Presenter(s):Marc L. Schermerhorn, MD | |
8:07 AM - 8:14 AM | Panel Discussion |
END OF SESSION 65 | |
SESSION 66 SCHEDULE | |
Friday
SESSION 66:
NEW DEVELOPMENTS IN DISEASES OF MAJOR AORTIC BRANCHES
|
|
x | |
8:14 AM - 8:19 AM | Technique For Laparoscopic Treatment Of Arculate Ligament Syndrome And Celiac Compression: Is It A Better Way |
Presenter(s):Yves Alimi, MD | |
8:20 AM - 8:25 AM | Tips And Tricks For Minimal Touch Techniques To Avoid Atheroembolization During Renal And Visceral PTA And Stenting |
Presenter(s):Kim J. Hodgson, MD | |
8:26 AM - 8:31 AM | Renal And Visceral Artery Stenoses: When And How Are They Best Treated |
Presenter(s):Sebastian E. Debus, MD, PhD | |
8:32 AM - 8:37 AM | Late Breaking Results From The CORAL Trial And Other Information: What Is The Current Role For Renal Artery Stenting (RAS) |
Presenter(s):Thomas A. Sos, MD | |
8:38 AM - 8:43 AM | The Need For Distal Protection During RAS: When And How To Do It |
Presenter(s):Max Amor, MD | |
8:44 AM - 8:49 AM | Role For Covered Stents In Renal And Visceral Lesions: Technical Tips |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
8:50 AM - 8:55 AM | Viabahn And Gore Hybrid Grafts To Decrease Renal And Mesenteric Ischemia In Visceral Segment Debranching Procedures (Using The Lachat Concept) |
Presenter(s):Michael C. Stoner, MD | |
8:56 AM - 9:01 AM | Endovascular Treatment Of Acute Mesenteric Ischemia: Role Of First Look Laparoscopy |
Presenter(s):Joseph S. Giglia, MD | |
9:02 AM - 9:07 AM | Endovascular Treatment Of 3 Mesenteric Arteries: When Is It Indicated And Needed |
Presenter(s):Furuzan Numan, MD | |
HYPOGASTRIC ARTERIES DURING EVAR | |
9:08 AM - 9:13 AM | Tips And Tricks For Coil Occlusion Of Hypogastric Arteries Using A New Large Volume Detachable Coil: The Penumbra RUBY Coil |
Presenter(s):Frank R. Arko, MD | |
9:14 AM - 9:19 AM | Technique And Long-Term Results Of The Trifurcated Endograft Method For Hypogastric Revascularization During EVAR With Iliac Aneurysms |
Presenter(s):David J. Minion, MD | |
9:20 AM - 9:25 AM | Long-Term Results Of Sandwich Techniques For Complex Aorto-Iliac And Common Iliac Aneurysms: The Brazilian Registry Shows Them To Be Better Than Hypogastric Exclusion By Coil Embolization And Bell Bottom Techniques |
Presenter(s):Armando C. Lobato, MD, PhD | |
9:26 AM - 9:31 AM | New Off-The-Shelf Gore Branched Internal Iliac Device For Hypogastric Revascularization: Technique And Early Clinical Experience |
Presenter(s):Piergiorgio Cao, MD, FRCS | |
9:32 AM - 9:39 AM | Panel Discussion |
9:39 AM - 9:54 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 66 | |
SESSION 67 SCHEDULE | |
Friday
SESSION 67:
ISSUES RELATED TO BUSINESS, GOVERNMENT, HEALTH CARE REFORM, INDUSTRY AND ETHICS
|
|
x | |
9:54 AM - 9:59 AM | Unintentional Consequences Of Disruptive Technology |
Presenter(s):Edward B. Diethrich, MD | |
10:00 AM - 10:05 AM | Is It Time For Physicians To Unionize And Why |
Presenter(s):Timothy M. Sullivan, MD | |
10:06 AM - 10:11 AM | Will Vascular Surgeons Continue To Lead Vascular Surgery Within Vascular Centers Or Will Other Specialists Become Dominant As They Have In Many Important Institutions |
Presenter(s):Ramon Berguer, MD, PhD | |
10:12 AM - 10:17 AM | Differences In The Independent Or Monospecialty Status Of Vascular Surgery In Europe And The US: How Has Independence Helped Vascular Surgery In Europe |
Presenter(s):Florian Dick, MD | |
10:18 AM - 10:23 AM | Are There Storm Clouds On The Horizon For Vascular Surgery: What Are They And What Can We Do About Them |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Abstract | |
10:24 AM - 10:29 AM | Impact Of Obamacare (ACA) On Vascular Surgeons/Specialists: How Will It Impact On The Way We Practice And Use Advanced Technology |
Presenter(s):Glenn Jacobowitz, MD | |
10:30 AM - 10:35 AM | Impact Of Obamacare (ACA) On American Medicine: An Industry Point Of View |
Presenter(s):Kem Hawkins, MBA | |
10:36 AM - 10:41 AM | Impact Of Obamacare (ACA) On American Medicine: Will it Be As Bad As We Fear: An Academic And Clinical Leader’s Point Of View |
Presenter(s):Clifford J. Buckley, MD | |
10:42 AM - 10:47 AM | Impact Of Obamacare On Vascular Surgery: An SVS And Government Relations Leader’s Point Of View |
Presenter(s):Robert M. Zwolak, MD, PhD | |
10:48 AM - 10:53 AM | ABC Of ACOs/Shared Demonstration Project: Understanding The Program And The Reimbursement Impact: Will Vascular Surgeons Be Poor |
Presenter(s):Sean P. Roddy, MD | |
10:54 AM - 10:59 AM | Health Care And Physician Organization Models To Help Us Survive In The Next Decade |
Presenter(s):Barry T. Katzen, MD | |
OFFICE-BASED PRACTICE | |
11:00 AM - 11:05 AM | Office Based PAD Labs: How Can They Help Your Practice And What Equipment Is Needed |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
11:06 AM - 11:11 AM | Advantages Of An Office Based Angiosuite For An Academic Vascular Practice: Hurricane Sandy Did Us A Favor |
Presenter(s):Mark A. Adelman, MD | |
11:12 AM - 11:17 AM | Economic Advantages To Setting Up An Office Practice For Venous Procedures, Angiography And PTA: What Are The Pitfalls To Avoid And Is Duplex Essential |
Presenter(s):Enrico Ascher, MD | |
11:18 AM - 11:23 AM | Risks And Benefits Of Employment Contracts For Vascular Surgeons/Specialists |
Presenter(s):O. William Brown, MD, JD | |
View Abstract | |
11:24 AM - 11:29 AM | What To Do When A Jehovah’s Witness Requires A Blood Transfusion During Emergency Surgery |
Presenter(s):James W. Jones, MD, PhD, MHA | |
View Abstract | |
11:30 AM - 11:36 AM | Panel Discussion |
END OF SESSION 67 | |
SESSION 68 SCHEDULE | |
Friday
SESSION 68:
A TRIBUTE TO OUR MILITARY (8 AND 10-MINUTE TALKS)
|
|
x | |
11:36 AM - 11:44 AM | How Has The Treatment Of Battle Casualties Advanced Between Vietnam And Iraq And Afghanistan: A New Emergency Response Aortic Occlusion System (ER-AOS) For Hemorrhagic Shock Is On The Horizon |
Presenter(s):Todd E. Rasmussen, MD, FACS / Norman M. Rich, MD, FACS, DMCC | |
11:45 AM - 11:55 AM | Experiences Of A Surgeon Astronaut And His Comments About Today’s World |
Presenter(s):Lee M. Morin, MD, PhD | |
View Abstract | |
11:55 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 68 | |
SESSION 69 SCHEDULE | |
Friday
SESSION 69:
INTERESTING HOT TOPICS AND UPDATES
Moderators:Krassi Ivancev, MD, PhD / Anatoly V. Pokrovsky, MD
|
|
x | |
7:00 AM - 7:05 AM | Treatment Of Hematomas Following Arterial Punctures: How To Avoid Malpractice Claims |
Presenter(s):O. William Brown, MD, JD | |
View Abstract | |
7:06 AM - 7:11 AM | Technical Tips For Cracking And Paving With Bad Iliacs And Other Options For Patients With Poor Access |
Presenter(s):Timothy A. Resch, MD, PhD / Martin Malina, MD, PhD | |
7:12 AM - 7:17 AM | Prevention And Treatment Of A-V Fistulas After Fogarty Embolectomy And PTA |
Presenter(s):Jos C. van den Berg, MD, PhD | |
7:18 AM - 7:23 AM | Duplex Ultrasound As The Sole Imaging Technique For Treating CLI |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
7:24 AM - 7:29 AM | Advantages Of The Proteus Angioslide Embolic Capture Device For Treating Fem-Pop Disease: When Is It Indicated |
Presenter(s):Peter C.J. Goverde, MD | |
7:30 AM - 7:35 AM | With EVAR Its Not Just Anatomy: Race, Ethnicity And Gender Influence Outcomes And Cost |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Abstract | |
7:36 AM - 7:41 AM | What’s New In DES For Fem-Pop And BTK Lesions: Results Of The DESTINY 2 And PES BTK-70 Trials With Paclitaxil And Everolimus Eluting Stents |
Presenter(s):Koen Deloose, MD / Marc Bosiers, MD | |
7:42 AM - 7:47 AM | Two-Year Results Of The Protégé-Everflex Stent (EV-3) To Treat Popliteal Lesions: The DURABILITY-POP Trial |
Presenter(s):Patrick Peeters, MD | |
7:48 AM - 7:53 AM | Role And Importance Of The Anesthesiologist In Minimally Invasive Procedures |
Presenter(s):Carlo Setacci, MD | |
7:54 AM - 7:59 AM | What Is The Effect Of Smoking On The Prevalence Of AAA And Does Smoking Influence EVAR Outcome |
Presenter(s):Frans L. Moll, MD, PhD | |
8:00 AM - 8:05 AM | MMP-9 Is An Excellent Marker For Detecting Endoleaks After EVAR: How Should It Be Used |
Presenter(s):Geert Willem H. Schurink, MD, PhD | |
8:06 AM - 8:12 AM | Panel Discussion |
END OF SESSION 69 | |
SESSION 70 SCHEDULE | |
Friday
SESSION 70:
EXCITING NEW DEVELOPMENTS WITH ENDOVASCULAR GRAFTS AND DEVICES FOR EVAR AND FENESTRATED AND BRANCHED EVAR
Moderators:Stephan Haulon, MD / James F. McKinsey, MD
|
|
x | |
8:13 AM - 8:18 AM | Fate Of Visceral And Renal Stents And Covered Stents In Fenestrated And Branched Endovascular Repairs: They Are Not Perfect: How To Make Them Near Perfect |
Presenter(s):Piotr M. Kasprzak, MD | |
8:19 AM - 8:24 AM | DEBATE: 10-Year Experience With Fenestrated And Branched Endografts: The Procedures Work And Are Durable: Open Operations Are Procedures From The Past |
Presenter(s):Tara M. Mastracci, MD / Matthew J. Eagleton, MD / Roy K. Greenberg, MD | |
8:25 AM - 8:30 AM | DEBATE: Not So! Many Patients With TAAAs And Suprarenal AAAs Need Open Repair: Which Ones Do |
Presenter(s):Hazim J. Safi, MD | |
8:31 AM - 8:36 AM | Status Of Off-The-Shelf Devices For TAAAs: When Will They Be Available: What Proportion Of Patients Will Be Suitable |
Presenter(s):Timothy A.M. Chuter, DM | |
8:37 AM - 8:42 AM | Advantages And Limitations Of The Ventana Off-The-Shelf Fenestrated Device For Pararenal AAAs: Clinical Trial Results |
Presenter(s):Daniel G. Clair, MD | |
8:43 AM - 8:48 AM | Advantages And Limitations Of The Anaconda Fenestrated Graft For Juxta- And Pararenal AAAs |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
8:49 AM - 8:54 AM | Anaconda Fenestrated Graft: Short And Medium Term Results Of The First 100 UK Cases |
Presenter(s):Nick J. Burfitt, BSc, MB, BChir, MRCS, FRCR | |
8:55 AM - 9:00 AM | Advantages And Limitations Of The Jotec Branched Endograft For TAAAs |
Presenter(s):Johannes Lammer, MD | |
9:01 AM - 9:06 AM | Innovative New Concept For A Versatile And Simple Branched Endograft Featuring Multiple Bifurcations To Repair TAAAs, Revascularize Hypogastrics, Etc. |
Presenter(s):Patrick W. Kelly, MD | |
9:07 AM - 9:12 AM | Advantages And Limitations Of The Lombard Aorfix Endograft, Now FDA Approved In The US |
Presenter(s):Mark F. Fillinger, MD | |
9:13 AM - 9:22 AM | Panel Discussion |
Moderator(s): Kenneth Ouriel, MD, MBA, FACS, FACC / Calogero Presti, MD | |
9:23 AM - 9:28 AM | Novel EVAR Devices That Seal Differently: Newer Polymer-Based Devices Make Traditional Concepts Of Neck Length Obsolete |
Presenter(s):Syed M. Hussain, MD | |
9:29 AM - 9:34 AM | Update On The Status Of The Nellix Device: A Different Concept For EVAR: Can It Be Used To Treat Ruptured AAAs |
Presenter(s):Andrew Holden, MBChB | |
9:35 AM - 9:40 AM | Clinical Experience With The TriVascular Ovation Endograft For EVAR: Post Trial And Multicenter Experience Show Continued Good Results In The Real World |
Presenter(s):Sean P. Lyden, MD / Michael D. Dake, MD | |
9:41 AM - 9:46 AM | The Horizon Endograft: A New Concept In Endografting That Can Be Applied To Situations Requiring Branched Grafts |
Presenter(s):Ralf R. Kolvenbach, MD / Mario Lachat, MD | |
View Abstract | |
9:47 AM - 9:52 AM | Two-Year Results Of The ENGAGE Global Registry With The Endurant Graft For EVAR |
Presenter(s):Dittmar Boeckler, MD | |
9:53 AM - 9:58 AM | Why Totally Infrarenal Devices With Repositioning Capability Are Best For EVAR With AAAs That Have Hostile Necks |
Presenter(s):Carlos H. Timaran, MD | |
9:59 AM - 10:04 AM | Better Graft Apposition To The Aortic Neck Correlates With Sealing And Sac Regression After EVAR: An Advantage Of The Endologix AFX Endograft: Why Is This Endograft Different In This Regard |
Presenter(s):Mell B. Welborn III, MD / Jean-Paul de Vries, MD, PhD | |
10:05 AM - 10:10 AM | The US Experience With The Incraft Endograft For EVAR: The INSPIRATION Trial |
Presenter(s):Michel Makaroun, MD | |
10:11 AM - 10:16 AM | One-Year Results With The Cordis Incraft: The INNOVATION Trial |
Presenter(s):Giovanni Torsello, MD | |
View Abstract | |
10:17 AM - 10:22 AM | A New Better Off-The-Shelf Endograft With Internal Branches To Treat Most Pararenal AAAs |
Presenter(s):Marcelo Ferreira, MD | |
10:23 AM - 10:30 AM | Panel Discussion |
10:31 AM - 10:50 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 70 | |
SESSION 71 SCHEDULE | |
Friday
SESSION 71:
EXCITING NEW DEVELOPMENTS WITH ENDOGRAFT DEVICES FOR TEVAR AND AORTIC FIXATION WITH STAPLES
Moderators:Julie Ann Freischlag, MD / Gregg S. Landis, MD
|
|
x | |
10:50 AM - 10:55 AM | Challenges With TEVAR In The Aortic Arch: How Does The Gore C-TAG Device Help To Meet Them |
Presenter(s):Dittmar Boeckler, MD | |
10:56 AM - 11:01 AM | Advantages Of The Medtronic Valiant Captiva Device For TEVAR In Or Near The Arch |
Presenter(s):Giovanni Torsello, MD | |
View Abstract | |
11:02 AM - 11:07 AM | Advantages Of The Cook TX2 Pro-Form Low Profile Device For TEVAR In Or Near The Arch |
Presenter(s):Tilo Koelbel, MD, PhD | |
11:08 AM - 11:13 AM | Advantages Of The Bolton Relay Device For TEVAR In Or Near The Arch |
Presenter(s):Vicente Riambau, MD, PhD | |
View Abstract | |
11:14 AM - 11:19 AM | Status Of And Clinical Experience With The Embrella Cerebral Embolic Protection Device For Use During TEVAR And TAVR Procedures |
Presenter(s):Jeffrey P. Carpenter, MD | |
AORTIC FIXATION (STAPLING) DEVICES | |
11:20 AM - 11:25 AM | Heli-FX EndoAnchor System: When Should It Be Used And How Effective Is It In Stopping Migration And Endoleaks: How Durable Is It |
Presenter(s):David H. Deaton, MD | |
11:26 AM - 11:31 AM | Can The Heli-FX EndoAnchor Be Used To Treat Type I Endoleaks: An Overview Of The European Experience |
Presenter(s):Jean-Paul de Vries, MD, PhD / Dittmar Boeckler, MD | |
11:32 AM - 11:37 AM | Heli-FX EndoAnchors To Improve Fixation Of Aortic Endografts: When Are They Needed And Do They Decrease Secondary Interventions: Worldwide Experience With 200 Patients From The ANCHOR Registry |
Presenter(s):William D. Jordan, Jr., MD | |
View Abstract | |
11:38 AM - 11:43 AM | The Lombard Stapling Device For Endograft Fixation: When Will It Become Available |
Presenter(s):Brian R. Hopkinson, ChM, FRCS | |
11:44 AM - 11:49 AM | Use Of The Heli-FX EndoAnchors In TEVAR: How To Resolve Problems In Complex Or Failing Cases |
Presenter(s):Luis A. Sanchez, MD | |
11:50 AM - 12:00 PM | Panel Discussion End Of Program K |
12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 71 | |
SESSION 72 SCHEDULE | |
Friday
SESSION 72:
MORE LOWER EXTREMITY HOT TOPICS AND THE MULTILAYER STENT
Moderators:Keith D. Calligaro, MD / William D. Suggs, MD
|
|
x | |
7:00 AM - 7:05 AM | When Is Distal Embolic Protection Needed In Infrainguinal Interventions: How To Do It |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Abstract | |
7:06 AM - 7:11 AM | When Is Distal Embolic Protection Needed For SFA Interventional Procedures: How Should It Be Done |
Presenter(s):Nicholas J. Morrissey, MD | |
7:12 AM - 7:17 AM | Multicenter Analysis Of Early Tibial Bypass Patency: Comparison Of Different Conduits And Configurations |
Presenter(s):Richard F. Neville, MD | |
View Abstract | |
7:18 AM - 7:23 AM | DEBATE: Some CLI Patients Do Better With A Bypass First Strategy: Which Ones |
Presenter(s):Michael S. Conte, MD | |
7:24 AM - 7:29 AM | DEBATE: An Endo First Strategy Is Better For All CLI Patients: However, PTA Is Not Perfect But Will Be With Improvements That Are On The Horizon: What Is The Relevance Of Gap Analysis |
Presenter(s):Krishna J. Rocha-Singh, MD | |
7:30 AM - 7:35 AM | Infrapopliteal PTA Works Well Up To 5 Years For CLI If Lesions Are Short But Not For Long Lesions In Poor Bypass Candidates: Nature Of Disease Not Open vs. Endo Determines Outcome |
Presenter(s):Marc L. Schermerhorn, MD | |
7:36 AM - 7:41 AM | Panel Discussion |
Moderator(s): Giorgio M. Biasi, MD / Givi A. Tsitsuashvili, MD, PhD | |
7:42 AM - 7:47 AM | DEBs And DESs In Infrapopliteal Arteries: With DEBs Is There Still A Role For Stenting |
Presenter(s):Fabrizio Fanelli, MD | |
7:48 AM - 7:53 AM | A New Better Device For Continuous Mechanical/Aspiration Thrombectomy For Lower Extremity Arteries And With Less Blood Loss And Hemolysis: The Penumbra Indigo System |
Presenter(s):Richard R. Saxon, MD | |
7:54 AM - 7:59 AM | Can Direct Puncture Of Occluded Stents Facilitate Retrograde Crossing And Recanalization Of Long Occlusions That Cannot Be Crossed Antegrade: How To Do It |
Presenter(s):Giancarlo Biamino, MD, PhD | |
8:00 AM - 8:05 AM | RC Trial Comparing Standard Thrombolysis With Ultrasound Enhanced Thrombolysis In Lower Extremity Ischemia: The DUET Trial |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
8:06 AM - 8:11 AM | Updated Strategies To Treat Acute Arterial Complications Of Total Knee And Hip Replacements: Should The Treatment Be Endovascular |
Presenter(s):Keith D. Calligaro, MD | |
View Abstract | |
8:12 AM - 8:17 AM | How Well Does Current Non-Operative And Non-Interventional Treatment Work For Intermittent Claudication: In What Proportion Of Patients Is Intervention/Operation Justified |
Presenter(s):Peter Henke, MD | |
8:18 AM - 8:23 AM | How To Do Interventional Procedures In Patients With Ehlers-Danlos Syndrome |
Presenter(s):James H. Black III, MD | |
8:24 AM - 8:29 AM | How To Make Office Based Interventions Economically Favorable: Is IVUS Helpful And Cost Effective |
Presenter(s):Paul J. Gagne, MD | |
8:30 AM - 8:37 AM | Panel Discussion |
MORE ABOUT THE MULTILAYER FLOW MODULATING (MLFM) STENT FOR ANEURYSM TREATMENT | |
Moderator(s): Kenneth Ouriel, MD, MBA, FACS, FACC / Frans L. Moll, MD, PhD | |
8:38 AM - 8:43 AM | Peripheral And Visceral Artery Aneurysms: Cardiatis Multilayer Flow Modulating (MLFM) Uncovered Stent Provides Effective Treatment |
Presenter(s):Claudio Rabbia, MD, PhD / Maria Antonella Ruffino, MD | |
8:44 AM - 8:49 AM | German Registry Experience With The MLFM Stent In The Treatment Of Aortic Aneurysms |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Abstract | |
8:50 AM - 8:55 AM | Two-Year Single Center Experience With MLFM Stents For Treatment Of Challenging Complex Aortic Aneurysms: Are These Uncovered Stents An Effective Treatment Based On Sac Size And Pressure Measurements: What Is Their Role |
Presenter(s):Thomas Larzon, MD, PhD | |
8:56 AM - 9:01 AM | Mechanisms Involved In The Way MLFM Stents Treat Aortic Aneurysms: How The Induced Sac Thrombosis Could Prevent Rupture |
Presenter(s):Jean-Marc Alsac, MD, PhD / Jean-Baptiste Michel, MD, PhD | |
View Abstract | |
9:02 AM - 9:07 AM | MLFM Uncovered Stents Will Never Replace Branched And Fenestrated Grafts For The Treatment Of Complex Aortic Aneurysms: A Skeptic’s View |
Presenter(s):Timothy A.M. Chuter, DM | |
9:08 AM - 9:13 AM | A Positive 2-Year Experience With Use Of the Multilayer Flow Modulating Stent To Treat Complex Aortic Aneurysms With Follow-Up Data On Aneurysm Size Changes And Rupture Risk |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC / Niamh Hynes, MD | |
9:14 AM - 9:22 AM | Panel Discussion |
9:23 AM - 9:40 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 72 | |
SESSION 73 SCHEDULE | |
Friday
SESSION 73:
MORE HOT TOPICS RELATED TO THE AORTA, ITS BRANCHES AND ANEURYSMS
Moderators:James C. Stanley, MD / John H. Furtek, BS, RT(r)
|
|
x | |
9:40 AM - 9:45 AM | Duodenal De-Rotation For SMA Compression Of The Duodenum: When And How To Do It |
Presenter(s):William J. Quinones-Baldrich, MD | |
9:46 AM - 9:51 AM | The Worst Patients For EVAR Are The Best For Minimally Invasive Open Repair Which Is Better Than FEVAR: Tips And Tricks For Minilap Open Repair |
Presenter(s):Francesco Spinelli, MD | |
View Abstract | |
9:52 AM - 9:57 AM | How Do Infrarenal Neck Morphology Changes Compare After EVAR And Open Repair: OR Was Pretty Good: From The DREAM Trial |
Presenter(s):Jan D. Blankensteijn, MD | |
9:58 AM - 10:03 AM | Tips And Tricks For Explanting Failed EVAR Endografts Safely |
Presenter(s):Afshin Assadian, MD | |
10:04 AM - 10:09 AM | Why Is Limb Thrombosis More Frequent With Low Profile EVAR Devices: How To Prevent And Treat It |
Presenter(s):Ronald M. Fairman, MD | |
10:10 AM - 10:15 AM | Profile vs. Durability In Aortic Endografts: What Is The Best Tradeoff |
Presenter(s):Scott L. Stevens, MD | |
10:16 AM - 10:21 AM | Effective Post-EVAR Surveillance Saves Lives: What Are The Best Reasonable Strategies Now And Moving Forward |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
10:22 AM - 10:27 AM | EVAR With Lower Profile: What Is The Future And What Concerns Should We Have |
Presenter(s):Michel Makaroun, MD | |
10:28 AM - 10:38 AM | Panel Discussion |
Moderator(s): Krassi Ivancev, MD, PhD / Jonathan S. Deitch, MD | |
10:39 AM - 10:44 AM | Effect Of Experience And Learning Curve On FEVAR: Are More Fenestrations Good Or Bad |
Presenter(s):Timothy A. Resch, MD, PhD | |
10:45 AM - 10:50 AM | A Progressively Compliant Endograft: Theoretical Advantages For Aortic Dissections And Other Conditions |
Presenter(s):Juan C. Parodi, MD | |
10:51 AM - 10:56 AM | The Optimal 3D Imaging And Planning For Complex AAA Repair By EVAR: It Is Getting Better |
Presenter(s):Lieven F. Maene, MD | |
10:57 AM - 11:02 AM | Benefits Of Innova Vision Technology With The GE Discovery System Makes Complex AAA Repair Simpler And Requires Less Radiation And Contrast |
Presenter(s):Stephan Haulon, MD | |
11:03 AM - 11:08 AM | DEBATE: Most Coarctations, Re-Coarctations, And Related Aneurysms Should Be Treated Endovascularly |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
11:09 AM - 11:14 AM | DEBATE: Not So! Some Of These Complex Coarctation Patients Require Open Repair |
Presenter(s):Joseph S. Coselli, MD | |
11:15 AM - 11:20 AM | How Does The Turn-Down Rate For Definitive Treatment Affect Overall And Procedural Mortality Rates For Ruptured AAAs In The US: How Can These Rates Be Improved |
Presenter(s):John J. Ricotta, MD | |
11:21 AM - 11:26 AM | Asymptomatic Renal Artery Aneurysms: When Should They Be Treated: Do We Really Know: What Is The Best Data |
Presenter(s):Peter F. Lawrence, MD | |
11:27 AM - 11:32 AM | Final Results Of The PEVAR (Percutaneous EVAR) Trial: PEVAR Is Best Except In What Circumstances: What Is Missing From The PEVAR Trial |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
11:33 AM - 11:45 AM | Panel Discussion End Of Program L |
11:45 AM - 1:00 PM | Lunch Break – Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floor) |
END OF SESSION 73 | |
SESSION 74 SCHEDULE | |
Friday
SESSION 74:
ISSUES RELATED TO TRAINING, CERTIFICATION, SPECIALIZATION, SIMULATION, RANDOMIZED CONTROLLED TRIALS (RCTs)
Moderators:John F. Eidt, MD / Karl A. Illig, MD
|
|
x | |
1:00 PM - 1:05 PM | Update On 0+5 Vascular Surgical Residencies: How Well Are They Working |
Presenter(s):Peter Henke, MD | |
1:06 PM - 1:11 PM | Comparison Of Vascular Surgery, Interventional Radiology And Interventional Cardiology Training Positions And Those Filling Them: Work Force Issues And Is Vascular Surgery Vulnerable |
Presenter(s):John F. Eidt, MD | |
1:12 PM - 1:17 PM | What Specialists Performs EVAR In The United States: From The Entire Medicare Database Since 2002: Which Specialty Does It Best: The Results Are Surprising |
Presenter(s):Ramon Berguer, MD, PhD / Jordan Knepper, MD | |
1:18 PM - 1:23 PM | Effect Of Surgeon Specialty And Volume On The Outcomes Of CEA |
Presenter(s):Ali F. AbuRahma, MD | |
View Abstract | |
1:24 PM - 1:29 PM | How To Shift The Learning Curve From The Patient To The Model Or Simulator: Rationale And Scope Of The International Vascular Training Courses |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
1:30 PM - 1:35 PM | Improving Endovascular Ruptured AAA Treatment By Simulation: Is Patient Specific Simulation Using Their CTA On The Horizon |
Presenter(s):Isabelle Van Herzeele, MD, PhD | |
1:36 PM - 1:41 PM | DEBATE: Randomized Controlled Trials (RCTs) And Level I Evidence Is The Best Guide To Good Medical Practice |
Presenter(s):Peter R. Taylor, MA, MChir, FRCS, ARCM | |
View Abstract | |
1:42 PM - 1:47 PM | DEBATE: Nonsense, RCTs And Level I Evidence May Be Misleading And Not Lead To Best Medical Practice |
Presenter(s):Michael D. Dake, MD | |
1:48 PM - 1:53 PM | Why Are So Many Important Clinical Trials Falling Short Of Their Goals: What Are Their Flaws And How May They Be Prevented |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
1:54 PM - 1:59 PM | Why Can RCTs Be Misleading And Misinterpreted: Is Bias Ever A Consideration |
Presenter(s):Timothy M. Sullivan, MD | |
2:00 PM - 2:05 PM | Why Randomization And RCT Data Is Over-Rated And Over-Valued As A Measure Of Evidence Quality |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
2:06 PM - 2:11 PM | RCTs: Are They A Quest For The Truth Or A Means To An End |
Presenter(s):Francesco Liistro, MD | |
2:12 PM - 2:17 PM | The Impact Of Evidence On Current Practice |
Presenter(s):Roger M. Greenhalgh, MD | |
2:18 PM - 2:35 PM | Panel Discussion And Break Visit Exhibits and Pavilions (2nd and 3rd Floor) |
END OF SESSION 74 | |
SESSION 75 SCHEDULE | |
Friday
SESSION 75:
FDA, REGISTRIES, HEALTH CARE REFORM, CONFLICT OF INTEREST, COST ISSUES, IMPROVING VASCULAR CARE
Moderators:Bruce A. Perler, MD, MBA / Frank J. Veith, MD
|
|
x | |
2:35 PM - 2:40 PM | What Is Off-Label Use: New Verdict, And New Rules And What They Mean For Vascular Surgeons And Vascular Specialists |
Presenter(s):O. William Brown, MD, JD | |
View Abstract | |
2:41 PM - 2:46 PM | What Is The FDA Doing To Help With Vascular Device Innovation |
Presenter(s):Dorothy B. Abel, BSBME | |
2:47 PM - 2:52 PM | The Rise And Demise Of Medical Technology In The US: Why I Am Working With The FDA And Will It Do Any Good |
Presenter(s):Thomas J. Fogarty, MD | |
2:53 PM - 2:58 PM | How To Get An Investigator Sponsored IDE From The FDA In 2013 |
Presenter(s):Joseph J. Ricotta II, MD, MS | |
2:59 PM - 3:04 PM | SVS VQI Update: Benefits, Challenges, Downsides |
Presenter(s):Jack L. Cronenwett, MD | |
3:05 PM - 3:10 PM | Identifying And Attacking The Top 5 Economic Challenges Of Obamacare (ACA) |
Presenter(s):Michael R. Jaff, DO | |
3:11 PM - 3:16 PM | Why Current Conflict Of Interest (COI) Policy Is A Farce |
Presenter(s):David H. Deaton, MD | |
3:17 PM - 3:22 PM | Calculating Total Cost For Vascular Procedures In The ACO Era |
Presenter(s):Timothy M. Sullivan, MD | |
3:23 PM - 3:28 PM | The Disconnect Between The Value To Patients And The Value To Hospitals For Complex Vascular Care: What Can Be Done To Fix The Problem |
Presenter(s):Michael C. Stoner, MD | |
3:29 PM - 3:34 PM | Cost Analysis Of Different Treatment Strategies For Non-Embolic Acute Limb Ischemia |
Presenter(s):Fedor Lurie, MD, PhD | |
3:35 PM - 3:41 PM | What VASCULAR SPECIALIST – Our SVS Newspaper – Has Meant To US Vascular Surgeons And What Is Its Future |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
3:42 PM - 3:47 PM | New Readmission Policies And Their Impact On Vascular Patients: Will Their Care Be Compromised |
Presenter(s):K. Craig Kent, MD | |
3:48 PM - 3:53 PM | All Vascular Surgery Should Be Centralized In High Volume Centers: Who Will Be Unhappy And Will It Happen |
Presenter(s):Ian Loftus, MD | |
View Abstract | |
3:54 PM - 3:59 PM | How Does Porter’s 5 Forces Model Impact On Vascular Surgery And What Should Individual Vascular Surgeons Do About It |
Presenter(s):Bauer E. Sumpio, MD, PhD | |
4:00 PM - 4:07 PM | Panel Discussion |
END OF SESSION 75 | |
SESSION 76 SCHEDULE | |
Friday
SESSION 76:
NATURAL HISTORY OF VASCULAR DISEASE, ADVANCES IN MEDICAL TREATMENT AND PREVENTION
Moderators:Ronald L. Dalman, MD / Anton N. Sidawy, MD, MPH
|
|
x | |
4:07 PM - 4:12 PM | What’s New With Endovascular Ablation Procedures For Atrial And Ventricular Arrhythmias: Why They Are Important To All Vascular Specialists |
Presenter(s):Larry Chinitz, MD | |
4:13 PM - 4:18 PM | Will Ezetimibe Have Increased Value When Added To Statins (Lipitor, Etc.) Over Statins Alone: What Does Ezetimibe Do |
Presenter(s):Don Poldermans, MD | |
View Abstract | |
4:19 PM - 4:24 PM | All Vascular Surgery Patients Should Have Perioperative Troponin Measurements: Why And How Do They Help In Patient Management |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
4:25 PM - 4:30 PM | Increased Troponins And MIs In Vascular Surgical Patients Indicates Decreased 5-Year Survival: What Can Be Done To Improve This Poor Survival |
Presenter(s):Andres Schanzer, MD | |
4:31 PM - 4:36 PM | Genome Based Antiplatelet Treatment Will Improve Patient Outcomes In Patients With CAD And PAD |
Presenter(s):Karthikeshwar Kasirajan, MD | |
4:37 PM - 4:42 PM | How To Decrease Cardiac Mortality In Diabetic Patients With CLI |
Presenter(s):Francesco Liistro, MD | |
4:43 PM - 4:48 PM | DEBATE: Does Doxycline Treatment Help Keep Small AAAs Small: A RCT Shows That It Doesn’t Help |
Presenter(s):Jan H.N. Lindeman, MD, PhD | |
4:49 PM - 4:54 PM | DEBATE: The Doxycline Story Is Not Over: Another Trial Is Needed: Are There Other Drugs That Will Keep Small AAAs Small |
Presenter(s):John A. Curci, MD | |
4:55 PM - 5:00 PM | DEBATE: Screening Is Worthwhile In PVD Patients For Carotid Disease, Etc. |
Presenter(s):Glenn Jacobowitz, MD | |
5:01 PM - 5:06 PM | DEBATE: Screening Is Not Worthwhile: We Should ONLY Look For Atherosclerotic Disease When Symptoms Arise |
Presenter(s):Erich Minar, MD | |
5:07 PM - 5:12 PM | Initial Findings, Costs And Surgical Consequences Of Screening For AAA, PAD And Hypertension: Danish Population-Based RCT (VIVA) Of 50,000 65-74 Year Old Men: Is It Worthwhile |
Presenter(s):Jes S. Lindholt, MD | |
5:13 PM - 5:18 PM | What Is Happening With Cardiomems For AAA And PA Pressure Monitoring: Does It Have A Future |
Presenter(s):Ross Milner, MD | |
5:19 PM - 5:24 PM | Upper Extremity BP Differential Is A Marker For PAD, Carotid Disease And CAD: Is It Better Than ABIs |
Presenter(s):Caron B. Rockman, MD | |
5:25 PM - 5:35 PM | Panel Discussion End Of Program M |
END OF SESSION 76 | |
SESSION 77 SCHEDULE | |
Friday
SESSION 77:
NEW TECHNIQUES, CONCEPTS AND UPDATES
Moderators:Ali F. AbuRahma, MD / A. Ross Naylor, MD, FRCS
|
|
x | |
1:00 PM - 1:05 PM | The Statin-Iron Nexus: Iron Reduction As An Alternative To Statins; Its Basis And How To Do It |
Presenter(s):Ralph G. DePalma, MD | |
View Abstract | |
1:06 PM - 1:11 PM | Microbubbles Can Facilitate Local Catheter Directed Thrombolysis And Decrease Systemic Side Effects: How Does The Technology Work |
Presenter(s):Kak Khee Yeung, MD, PhD / Willem Wisselink, MD | |
View Abstract | |
1:12 PM - 1:17 PM | Update On New Medications For Treating Lipid Abnormalities |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
1:18 PM - 1:23 PM | Do We Need To Stop Plavix Before Open Vascular Surgery |
Presenter(s):Jack L. Cronenwett, MD | |
1:24 PM - 1:29 PM | Tips And Tricks For Successful PEVAR 100% Of The Time |
Presenter(s):Firas F. Mussa, MD | |
1:30 PM - 1:35 PM | Long-Term Survival With Thoracic Aneurysms Is Worse After TEVAR Than Open Repair: This Does Not Mean We Should Abandon TEVAR |
Presenter(s):Philip P. Goodney, MD, MS | |
View Abstract | |
1:36 PM - 1:41 PM | Stem Cell Mobilization Improves Amputation Rates In CLI: What Is the Mechanism; How Can It Be Done Simply And Is It Better Than Stem Cell Transplantation |
Presenter(s):Eric T. Choi, MD | |
1:42 PM - 1:47 PM | CTO Crossing Techniques Using Only Catheters And Wires: How Often Are Special Devices Needed For Bailout: What Should Be In Your Toolbox |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Abstract | |
1:48 PM - 1:53 PM | DEBATE: How Bad Is A Minor MI After CAS Or CEA: It Is Equivalent To A Stroke |
Presenter(s):Peter A. Schneider, MD | |
View Abstract | |
1:54 PM - 1:59 PM | DEBATE: Not So! In CREST A Minor Stroke Had A Worse Effect On Quality Of Life And As Bad An Effect On 4-Year Mortality As An MI |
Presenter(s):Thomas G. Brott, MD | |
2:00 PM - 2:05 PM | Updated Gender Differences In CAS vs. CEA Outcomes From CREST And The SVS Registry Indicate That CAS Is Rarely Justified In Women |
Presenter(s):Kosmas I. Paraskevas, MD / Dimitri P. Mikhailidis, MD / Christos D. Liapis, MD / Frank J. Veith, MD | |
View Abstract | |
2:06 PM - 2:30 PM | Panel Discussion And Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 77 | |
SESSION 78 SCHEDULE | |
Friday
SESSION 78:
NEW TECHNOLOOGY, TECHNIQUES, CONCEPTS AND UPDATES RELATED TO LOWER EXTREMITY, CAROTID AND VISCERAL ARTERY DISEASE
Moderators:Patrick J. Lamparello, MD / Lucien D. Castellani, MD
|
|
x | |
2:30 PM - 2:35 PM | Tips And Tricks For Doing Most Peripheral Interventions Via The Radial Artery |
Presenter(s):Ivo Petrov, MD, PhD | |
LOWER EXTREMITY TOPICS | |
2:36 PM - 2:41 PM | Open vs. Endovascular For Peripheral Aneurysms Including Popliteals: Outcomes Of Stent-Graft Exclusion Can Be Equivalent Or Better Than Open Repair (OR) If Certain Patients Are Excluded: Who Should Get OR |
Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS | |
2:42 PM - 2:47 PM | Interventional Strategy For Large Popliteal Aneurysms With Tortuous Anatomy |
Presenter(s):Jacques Busquet, MD | |
2:48 PM - 2:53 PM | The Multispecialty BEST CLI Trial: What It Will Tell Us About The Treatment Of Lower Extremity CLI And Why It Is Unique |
Presenter(s):Matthew T. Menard, MD / Kenneth Rosenfield, MD / Alik Farber, MD / Michael D. Dake, MD / Michael S. Conte, MD | |
2:54 PM - 2:59 PM | Tips And Tricks For Sartorius Muscle Flaps For Groin Complications After Vascular Procedures: How To Make Them Work |
Presenter(s):Fred A. Weaver, MD | |
View Abstract | |
3:00 PM - 3:05 PM | DEBATE: Subintimal PTA Is Superior To SilverHawk Atherectomy For Lower Extremity Occlusive Lesions |
Presenter(s):Jeffrey Indes, MD | |
3:06 PM - 3:11 PM | DEBATE: Not So! The SilverHawk Atherectomy Device Is A Valuable Tool If Used Correctly |
Presenter(s):James F. McKinsey, MD | |
3:12 PM - 3:17 PM | How Can OCT (Optical Coherence Tomography) Help In The Treatment Of Peripheral Arterial Lesions |
Presenter(s):Vikram S. Kashyap, MD | |
3:18 PM - 3:23 PM | How To Perform A To Z Revascularization Of Tibial Arteries Quickly And With High Success: How To Make Them Durable |
Presenter(s):Craig M. Walker, MD | |
3:24 PM - 3:29 PM | Toe And Foot Osteomyelitis: How To Diagnose And Treat It: Medical vs. Surgical |
Presenter(s):Wayne J. Caputo, DPM | |
3:30 PM - 3:35 PM | Restoring The Reputation Of Spliced Arm Veins For Lower Extremity Bypasses |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
3:36 PM - 3:43 PM | Panel Discussion |
CAROTID, VISCERAL, RENAL TOPICS | |
Moderator(s): Michel Makaroun, MD / Christos D. Liapis, MD | |
3:43 PM - 3:48 PM | Urgent CAS For Acutely Symptomatic Carotid Stenosis Works Fine And Has Good Outcomes If Certain Tips, Techniques And Strategies Are Followed |
Presenter(s):Gioacchino Coppi, MD | |
3:49 PM - 3:54 PM | A RC Trial Comparing Acuseal (PTFE) With Bovine Pericardium For Patching During CEA: Which Is Best And Why |
Presenter(s):Patrick A. Stone, MD | |
3:55 PM - 4:00 PM | DEBATE: Completion Imaging Should Be Performed After CEA |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
4:01 PM - 4:06 PM | DEBATE: Completion Imaging Is Not Needed After CEA |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
4:07 PM - 4:12 PM | How Does Routine Completion Angioscopy Decrease The Stroke Rate After CEA |
Presenter(s):A. Ross Naylor, MD, FRCS | |
4:13 PM - 4:18 PM | Retrograde Mesenteric PTA And Stent For Mesenteric Ischemia: Chronic And Acute |
Presenter(s):Edward Y. Woo, MD | |
4:19 PM - 4:24 PM | Stenting Of Renal Artery Stenosis Is Better Than Medical Treatment: Results Of The RADAR Trial |
Presenter(s):Thomas Zeller, MD | |
4:25 PM - 4:31 PM | Panel Discussion |
END OF SESSION 78 | |
SESSION 79 SCHEDULE | |
Friday
SESSION 79:
NEW TECHNOLOGY, TECHNIQUES, CONCEPTS AND UPDATES RELATED TO AORTIC DISEASE
Moderators:Peter F. Lawrence, MD / Julie Ann Freischlag, MD
|
|
x | |
4:32 PM - 4:37 PM | All Acute Type B Aortic Dissections Are Complicated And Should Be Treated Interventionally |
Presenter(s):Frank R. Arko, MD | |
4:38 PM - 4:43 PM | Natural History Of Untreated Large AAAs In Patients Too Sick To Treat In The Modern Era: Is Prognosis Better Than We Thought |
Presenter(s):Katariina M. Noronen, MD / Maarit Venermo, MD / Mauri J.A. Lepantalo, MD | |
View Abstract | |
4:44 PM - 4:49 PM | Results Of The ECAR RCT Comparing EVAR And Open Repair For Ruptured AAAs: Why It Is Not Definitive Or Is It |
Presenter(s):Pascal Desgranges, MD, PhD | |
4:50 PM - 4:55 PM | What Is The Importance Of Biomarkers In Patients With AAA Disease |
Presenter(s):Ronald L. Dalman, MD | |
4:56 PM - 5:01 PM | Alternate Approaches To Hypogastric Revascularization During EVAR: Is There Still A Role For Open Revascularization Or Occlusion Without Revascularization |
Presenter(s):Arno von Ristow, MD | |
View Abstract | |
5:02 PM - 5:07 PM | Fate Of The Distal Aorta In Marfan’s Patients: How To Follow Them And Manage Them |
Presenter(s):Joseph S. Coselli, MD | |
View Abstract | |
5:08 PM - 5:13 PM | Wrapping Of Dilated Ascending Aorta To Facilitate Clamping, And Debranching That Is Otherwise Not Possible |
Presenter(s):Mario Lachat, MD | |
5:14 PM - 5:19 PM | How To Prevent Strokes During And After TEVAR |
Presenter(s):Bart E. Muhs, MD, PhD | |
5:20 PM - 5:30 PM | Panel Discussion End Of Program N |
END OF SESSION 79 | |
SESSION 80 SCHEDULE | |
Friday
SESSION 80:
NEW DEVELOPMENTS IN EVAR, TEVAR, COMPLEX EVAR, LAPAROSCOPY AND RENAL DENERVATION
Moderators:Jean-Pierre Becquemin, MD, FRCS / Ronald M. Fairman, MD
|
|
x | |
1:00 PM - 1:05 PM | How To Decrease The Cost Of EVAR |
Presenter(s):Richard J. Powell, MD | |
1:06 PM - 1:11 PM | EVAR Is Better Than Open Repair: The Danish Registry Clearly Shows It In Comparable Patient Cohorts |
Presenter(s):Torben V. Schroeder, MD, DMSc | |
View Abstract | |
1:12 PM - 1:17 PM | Tips And Tricks On How To Place Palmaz Stents In Challenging EVAR Necks Accurately And Safely |
Presenter(s):Dieter Raithel, MD, PhD | |
View Abstract | |
1:18 PM - 1:23 PM | In Situ Fenestration To Revascularize Covered Hypogastric Arteries: Equipment And Technical Steps |
Presenter(s):Grayson H. Wheatley, MD | |
1:24 PM - 1:29 PM | Preoperative IMA Embolization Before EVAR: Is It Worthwhile And When |
Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
1:30 PM - 1:35 PM | Complex Iatrogenic Dissection Complicating TEVAR For (Degenerative) Aneurysm Of The Descending Aorta: Recognition And Management |
Presenter(s):Claude Mialhe, MD | |
View Abstract | |
1:36 PM - 1:41 PM | For Infected Paravisceral Aortic Grafts Cryopreserved Allografts Are A Good Treatment Option: How Should They Be Used |
Presenter(s):Mark D. Morasch, MD, FACS, RPVI | |
1:42 PM - 1:47 PM | Laparoscopic Aortofemoral Bypass Using A Clampless Sutureless Aortic Anastomotic Technique |
Presenter(s):Bernard J. Segers, MD | |
View Abstract | |
1:48 PM - 1:53 PM | Are There Potential Downsides To Renal Artery Denervation By Radiofrequency: What Damage To The Renal Artery Does It Cause And Are All Nerves Around The Artery Destroyed |
Presenter(s):Clemens Jilek, MD | |
1:54 PM - 2:02 PM | Panel Discussion |
TEVAR RELATED TOPICS | |
2:02 PM - 2:07 PM | Which Chronic Type B Aortic Dissection Should Be Treated With Fenestrated And Branched Endografts: Tips And Tricks For Doing This |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Abstract | |
2:08 PM - 2:13 PM | Fenestrated And Branched TEVAR Is Good Treatment For Some Chronic Type B Aortic Dissections: But At What Price |
Presenter(s):Marcelo Ferreira, MD | |
2:14 PM - 2:19 PM | When Should Aortic Branches Be Stented In The Treatment Of Complicated Acute Type B Aortic Dissections |
Presenter(s):Tara M. Mastracci, MD / Matthew J. Eagleton, MD / Roy K. Greenberg, MD | |
2:20 PM - 2:25 PM | Temporary Perfusion Branches Are The Way To Go To Decrease Spinal Cord Ischemia With Endovascular Repair Of TAAAs: Clinical Experience |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Abstract | |
2:26 PM - 2:31 PM | Branches With A Removable Plug To Decrease SCI After TAAA Endovascular Repair: Mechanism And Technique |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
2:32 PM - 2:37 PM | 3 Possible Techniques For Aortic Arch Repair Which Will Win Out |
Presenter(s):Eric E. Roselli, MD | |
2:38 PM - 2:51 PM | Panel Discussion |
2:51 PM - 3:10 PM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 80 | |
SESSION 81 SCHEDULE | |
Friday
SESSION 81:
NEW DEVELOPMENTS IN INNOVATION AND LOWER EXTREMITY AND CAROTID DISEASE
Moderators:Thomas J. Fogarty, MD / Albrecht H. Kramer, MD
|
|
x | |
3:10 PM - 3:15 PM | Advances In Interactive Telephone Technologies That Monitor And Improve Vascular Care Compliance |
Presenter(s):John (Jeb) W. Hallett, MD | |
3:16 PM - 3:21 PM | Nano And Microparticle Drug Delivery: How Will It Play A Role In Peripheral Arterial Interventions |
Presenter(s):Subhash Banerjee, MD | |
3:22 PM - 3:27 PM | Thrombosuction For Acute Limb Ischemia: Equipment, Technical Tips And Results |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Abstract | |
3:28 PM - 3:33 PM | External Iliac Arteriopathy (Endofibrosis) In Cyclists And Other Athletes: Recognition And Treatment |
Presenter(s):Kenneth J. Cherry, MD | |
3:34 PM - 3:39 PM | Life-Threatening Rupture In Vascular Ehlers-Danlos Syndrome: Is Endovascular Therapy Safe And Effective: Tips And Tricks That Help |
Presenter(s):Kyung Cho, MD | |
3:40 PM - 3:45 PM | Tips And Tricks For SFA Recanalization: Can Radiofrequency Help: Pitfalls |
Presenter(s):Marcelo S. Guimaraes, MD | |
3:46 PM - 3:51 PM | Endovascular Salvage Of Occluded Vascular Grafts: Tips And Tricks |
Presenter(s):Craig M. Walker, MD | |
3:52 PM - 3:57 PM | Novel Endovascular Technique To Administer Dexamethasone Into The Adventitia With Intent To Reduce Restenosis: 12-Month Results From The DANCE Pilot |
Presenter(s):Christopher D. Owens, MD | |
3:58 PM - 4:08 PM | Panel Discussion |
CAROTID RELATED TOPICS | |
Moderator(s): Giancarlo Biamino, MD, PhD / Richard M. Green, MD | |
4:09 PM - 4:14 PM | If CAS Experience Matters So Much, Why Are CAS Enthusiasts Pushing Everyone To Do CAS: Shouldn’t The Procedure Be Centralized |
Presenter(s):Klaus D. Mathias, MD | |
4:15 PM - 4:20 PM | What The Timing Of Strokes With CAS Tells Us About Their Pathogenesis: What Can Be Done To Decrease Stroke Rates |
Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
4:21 PM - 4:26 PM | Is There A Role For CAS With A Carotid String Sign |
Presenter(s):Carlos H. Timaran, MD | |
4:27 PM - 4:32 PM | Myths In The Interpretation Of The CREST Trial: Does An MI Have A Worse Effect On Late Mortality Than A Stroke: Is A Cranial Nerve Deficit Equivalent To A Stroke: Gender Has No Effect On Outcomes |
Presenter(s):Thomas G. Brott, MD | |
4:33 PM - 4:38 PM | DEBATE: What Is The Best Treatment For Most Patients With Asymptomatic High Grade Carotid Stenosis: CAS – A Surgeon Interventionalist’s View |
Presenter(s):Kim J. Hodgson, MD | |
4:39 PM - 4:44 PM | DEBATE: What Is The Best Treatment For Most Patients With Asymptomatic High Grade Carotid Stenosis: CAS – An Interventional Cardiologist’s View |
Presenter(s):Sriram S. Iyer, MD | |
4:45 PM - 4:50 PM | DEBATE: What Is The Best Treatment For Most Patients With Asymptomatic High Grade Carotid Stenosis: Best Medical Treatment: Another Surgeon’s View |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
4:51 PM - 4:56 PM | How To Perform CAS With Difficult Arch Anatomy Using Radial And Brachial Approaches: Tips And Tricks |
Presenter(s):Patrick E. Muck, MD, FACS | |
View Abstract | |
4:57 PM - 5:07 PM | Panel Discussion End Of Program O |
END OF SESSION 81 |